Inhibition of heat-shock protein 27 expression eliminates drug resistance of osteosarcoma to zoledronic acid.

Abstract

Resistance to ZOL in osteosarcoma cells may be induced by a molecular mechanism different from conventional efflux pump-based resistance. Up-regulation of HSP27 expression may play a role in the development of ZOL resistance in HOS cells.